A Case of Clozapine-induced Corneal and Lenticular Pigmentation. |
Ji Seon An, Young Mi Lee, Joo Young Kwag, Joo Hyun, Jin Seok Choi, Kyu Hong Pak, Sung Kun Chung |
1Saevit Eye Hospital, Goyang, Korea. eyekun@gmail.com 2Department of Pharmacy, Saevit Eye Hospital, Goyang, Korea. |
클로자핀 복용으로 유발된 각막 및 수정체 색소침착 1예 |
안지선1⋅이영미2⋅곽주영1⋅현 주1⋅최진석1⋅박규홍1⋅정성근1 |
새빛안과병원1, 새빛안과병원 약제실2 |
Correspondence:
Sung Kun Chung, Email: eyekun@gmail.com |
Received: 30 August 2018 • Revised: 7 November 2018 • Accepted: 19 February 2019 |
Abstract |
PURPOSE To report a case of corneal and lenticular pigmentation after prolonged clozapine therapy. CASE SUMMARY: A 56-year-old male visited our hospital with a progressive decline in vision that affected both eyes. He had a history of schizophrenia. He was being treated with 200 mg clozapine and 1 mg lorazepam daily, and had been treated with clozapine for 5 years. At the first visit, his best-corrected-visual acuity was 20/32 in both eyes. Slit lamp examination of the corneas showed bright, fine, grayish-brown deposits on the endothelium, and on dilation, bilateral central stellate opacity of the anterior portion of the lens capsule was revealed. CONCLUSIONS: Clozapine may induce corneal and lenticular pigmentation and thus may lead to a decline in vision. Patients on long-term clozapine therapy should be considered for regular ophthalmic review. |
Key Words:
Clozapine;Corneal pigmentation;Lenticular pigmentation |
|